Cargando…

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation

Detalles Bibliográficos
Autores principales: Minev, Boris, Kohrt, Holbrook, Kilinc, Mehmet, Chen, Nanhai, Feng, Audrey, Pessian, Maysam, Geissinger, Ulrike, Haefner, Erik, Tsoneva, Desislava, Bozhilov, Kliment, Sagiv-Barfi, Idit, Zhao, Xing, Rajesekaran, Narendiran, Levy, Ronald, Szalay, Aladar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288403/
http://dx.doi.org/10.1186/2051-1426-2-S3-P112
_version_ 1782351965116694528
author Minev, Boris
Kohrt, Holbrook
Kilinc, Mehmet
Chen, Nanhai
Feng, Audrey
Pessian, Maysam
Geissinger, Ulrike
Haefner, Erik
Tsoneva, Desislava
Bozhilov, Kliment
Sagiv-Barfi, Idit
Zhao, Xing
Rajesekaran, Narendiran
Levy, Ronald
Szalay, Aladar
author_facet Minev, Boris
Kohrt, Holbrook
Kilinc, Mehmet
Chen, Nanhai
Feng, Audrey
Pessian, Maysam
Geissinger, Ulrike
Haefner, Erik
Tsoneva, Desislava
Bozhilov, Kliment
Sagiv-Barfi, Idit
Zhao, Xing
Rajesekaran, Narendiran
Levy, Ronald
Szalay, Aladar
author_sort Minev, Boris
collection PubMed
description
format Online
Article
Text
id pubmed-4288403
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42884032015-01-15 Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation Minev, Boris Kohrt, Holbrook Kilinc, Mehmet Chen, Nanhai Feng, Audrey Pessian, Maysam Geissinger, Ulrike Haefner, Erik Tsoneva, Desislava Bozhilov, Kliment Sagiv-Barfi, Idit Zhao, Xing Rajesekaran, Narendiran Levy, Ronald Szalay, Aladar J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288403/ http://dx.doi.org/10.1186/2051-1426-2-S3-P112 Text en Copyright © 2014 Kohrt et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Minev, Boris
Kohrt, Holbrook
Kilinc, Mehmet
Chen, Nanhai
Feng, Audrey
Pessian, Maysam
Geissinger, Ulrike
Haefner, Erik
Tsoneva, Desislava
Bozhilov, Kliment
Sagiv-Barfi, Idit
Zhao, Xing
Rajesekaran, Narendiran
Levy, Ronald
Szalay, Aladar
Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title_full Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title_fullStr Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title_full_unstemmed Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title_short Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
title_sort combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288403/
http://dx.doi.org/10.1186/2051-1426-2-S3-P112
work_keys_str_mv AT minevboris combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT kohrtholbrook combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT kilincmehmet combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT chennanhai combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT fengaudrey combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT pessianmaysam combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT geissingerulrike combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT haefnererik combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT tsonevadesislava combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT bozhilovkliment combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT sagivbarfiidit combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT zhaoxing combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT rajesekarannarendiran combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT levyronald combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation
AT szalayaladar combinationimmunotherapywithoncolyticvacciniavirusandcheckpointinhibitorfollowinglocaltumorirradiation